MENU
NAUT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nautilus Biotechnolgy (NAUT) Ownership - Who owns Nautilus Biotechnolgy?
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome... Show more
Profile
Industry
N/A
Address
2701 Eastlake Avenue East
Phone
+1 206 333-2001
Employees
167
Web
https://www.nautilus.bio
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
94.83M
P/E Ratio
N/A
Total Cash
147.87M
Projected Growth
N/A
Total Debt
28.18M
Revenue
N/A
Risk (Beta)
1.62
Dividend Yield
N/A
Total Cash/Share
1.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NAUT
Capitalization
94.8M
P/E Ratio
N/A
Risk (Beta)
1.62
Dividend Yield
N/A
Total Cash
148M
Total Cash/Share
1.17
Total Debt
28.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
181M
P/B Ratio
0.52
Cash Flow
N/A
Earnings
-0.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
18.52
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-68.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.03
Shares Held By Institutions
40.7M
Shares Outstanding - Current
126M
Total Liabilities
32.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-55.310
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2701 Eastlake Avenue East
Phone
+1 206 333-2001
Employees
167
Web
https://www.nautilus.bio